Top Markets
#1 Akedo Akedo +62.21%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.61%
#4 Cross Cross +42.54%
#5 Black Phoenix Black Phoenix +34.09%
#6 Velvet Velvet +30.86%
#7 OVERTAKE OVERTAKE +24.86%
#8 Cap Cap +16.59%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.42%
#10 Bitway Bitway +12.57%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Exopharm Limited Exopharm Limited

Exopharm Limited

EX1
Classement en actions #39130
Exopharm Limited is an Australian clinical-stage firm dedicated to developing... Exopharm Limited is an Australian clinical-stage firm dedicated to developing groundbreaking therapeutics utilizing extracellular vesicles (EVs). Its core technologies include an extracellular vesicle positioning system (EVPS), which facilitates the precise targeting of exosomes by attaching specific molecules to their surface, guiding them to particular tissues or cell types. Another innovation is oligonucleotide packing, designed to optimize therapeutic delivery by preferentially loading specific RNA molecules into exosomes as medicinal cargo. Additionally, Exopharm employs ligand-based exosome affinity purification for effectively isolating and refining exosomes from biological fluids such as blood and cell culture media. The company's engineered EV product portfolio features Fortrexo CoV, aimed at treating SARS-CoV-2 infections; Cognevo, developed for neurodegenerative diseases; and PlexoDox, intended for cancer treatment. Exopharm Limited also maintains a research collaboration with Showa Denko Materials Co., Ltd. The company was founded in 2013 and is headquartered in Melbourne, Australia.
Prix de l'action
$0.00700343
Dernière synchronisation: 2023-10-30
Capitalisation boursière
$637.31K
Changement (1 jour)
0.50%
Changement (1 an)
0.00%
Pays
AU
Échange Exopharm Limited (EX1)

Catégorie

Healthcare
Historique du prix de l'action pour Exopharm Limited (EX1)
Prix de clôture le plus élevé : $0.01 le 2023-10-01

Prix de clôture le plus bas : $0.35 le 2018-12-01
Historique du prix de l'action de Exopharm Limited de 2018 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 -85.98%
2022 -83.97%
2021 9.37%
2020 40.18%
2019 -42.20%
2018 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $506.54 29.78%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $843.80 29.33%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $729.87 6.86%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $252.41 11.51%
BE